IBT B — Infant Bacterial Therapeutics AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for Infant Bacterial Therapeutics AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	423	387	336	329	223
Net Total Accounts Receivable
Net Total Receivables	1.96	1.2	1.78	6.74	4.77
Prepaid Expenses
Total Other Current Assets
Total Current Assets	438	397	339	342	231
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	450	408	350	351	240
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	10.2	13.2	17.9	46.2	69.3
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	10.2	13.2	17.9	46.2	69.3
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	440	395	332	305	170
Total Liabilities & Shareholders' Equity	450	408	350	351	240
Total Common Shares Outstanding